Immunogenicity and safety following primary and booster vaccination with a hexavalent diphtheria, tetanus, acellular pertussis, hepatitis B, inactivated poliovirus and Haemophilus...

por Klein, Nicola P., Abu-Elyazeed, Remon, Cheuvart, Brigitte, Janssens, Winnie, Mesaros, Narcisa
Publicado 2019

Immunogenicity and safety of primary and booster vaccination with 2 investigational formulations of diphtheria, tetanus and Haemophilus influenzae type b antigens in a hexavalent D...

por Vesikari, Timo, Rivera, Luis, Korhonen, Tiina, Ahonen, Anitta, Cheuvart, Brigitte, Hezareh, Marjan, Janssens, Winnie, Mesaros, Narcisa
Publicado 2017

Long-term antibody persistence against hepatitis B in adolescents 14–15-years of age vaccinated with 4 doses of hexavalent DTPa-HBV-IPV/Hib vaccine in infancy

por Schwarz, Tino F., Behre, Ulrich, Adelt, Thomas, Donner, Matthias, Suryakiran, Pemmaraju V., Janssens, Winnie, Mesaros, Narcisa, Panzer, Falko
Publicado 2018

Immunogenicity and safety of a combined DTPa-IPV/Hib vaccine administered as a three-dose primary vaccination course and a booster dose in healthy children in Russia: a phase III,...

por Romanenko, Victor, Osipova, Irina, Galustyan, Anna, Scherbakov, Michael, Baudson, Nathalie, Farhi, Déborah, Anaya, Luis, Kuriyakose, Sherine O., Meyer, Nadia, Janssens, Winnie
Publicado 2020